| Previous close | 3.50 |
| Open | 3.30 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 125.00 |
| Expiry date | 2024-08-16 |
| Day's range | 3.30 - 3.50 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksGlaukos (GKOS) Reaches 52-Week High: What's Driving the Stock?
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
ZacksGlaukos (GKOS) Stock Jumps 3.7%: Will It Continue to Soar?
Glaukos (GKOS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Business WireGlaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
ALISO VIEJO, Calif., June 14, 2024--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company, today announced that it entered into separate, privately negotiated exchange agreements (the "Exchange Agreements") with certain holders of its 2.75% Convertible Senior Notes due 2027 (the "Existing Convertible Notes"). Pursuant to these Exchange Agreements, the company agreed, subject to customary closing conditions, to repurchase an aggregate of $230 million princi
